AMERICAN BOARD OF ORAL PATHOLOGY (EIN 356042105) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1948

Legal Domicile

Principal Officer

Kevin R Torske

Phone

8132862444

Tax Period

2024-10-01 to 2025-09-30

AMERICAN BOARD OF ORAL PATHOLOGY, founded in 1948, is a small nonprofit in the Diseases & Disorders sector that reported $208K in total revenue in fiscal year 2024. Revenue decreased 5% compared to the prior year. Expenses of $186K left a modest 11% surplus.

Mission

Mission: Administer dental specialty board examination to eligible candidates 21; seventeen candidates were successful. Administer re-certification examination for 18 time-limited diplomates; 18 candidates were successful.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $99,950

Program Service Revenue $93,250

Investment Income $14,398

Other Revenue $0

TOTAL REVENUE $207,598

Expense Breakdown

Grants Paid $0

Salaries & Benefits $72,000

Fundraising Expenses $0

Program Expenses $145,790

Other Expenses $113,592

TOTAL EXPENSES $185,592

Year-over-Year Comparison

	2024	2023	Change
Revenue	$207,598	$218,676	-0.1%
Expenses	$185,592	$187,421	0.0%
Net Income	$22,006	$31,255	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Dr Angela Chi	President	3.00	Officer Director	$0	$0	$0
Dr Yeshwant Rawal	Vice President	2.00	Officer Director	$0	$0	$0
Dr Elizabeth Bilodeau	Director	1.00	Director	$0	$0	$0
Dr Kevin Torske	Secretary Treasurer	8.00	Officer Director	$0	$0	$0
Dr Kelly Magliocca	Director	1.00	Director	$0	$0	$0
Dr Robert Kelsh	Director	1.00	Director	$0	$0	$0
Dr Ricardo Padilla	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$207,598	$185,592	$958,622	$22,006
2024	$218,676	$187,421	$863,898	$31,255
2023	$164,598	$166,694	$747,714	$-2,096
2022	$164,988	$142,394	$711,613	$22,594
2021	$169,656	$132,193	$757,225	$37,463
2020	$154,210	$126,187	$719,762	$28,023

AMERICAN BOARD OF ORAL PATHOLOGY